Veristat is The Science-First CRO™, integrating full service clinical trial execution, regulatory consulting, and strategic planning to rapidly advance the development, approval, and commercialization of your revolutionary therapies around the globe. We specialize in supporting biopharma developing the most complex, novel, and rare therapies.

Visit Website


  • APAC
  • Europe
  • North America

Therapeutic Areas

  • Cardiovascular Disease
  • Endocrine/Metabolic
  • Infectious Disease
  • Inflammation/Immunology
  • More Therapy Areas
  • Neurology/Psychiatry
  • Oncology/Hematology

For 30 years, Veristat has helped pharmaceutical and biotech companies accelerate their clinical trials and commercialize their therapies by delivering Science-First solutions across the development lifecycle. From overcoming unprecedented challenges in drug and biologic study design, to efficient patient recruitment and retention for an ultra-rare disease, to intricate clinical trial conduct and scientifically vetted regulatory submissions, our global team of experts is big enough to tackle any unknown while small enough to give you the attention you need to hit your milestones faster.



Partners are trained on the functionality of the electronic data capture (EDC) and clinical data management (CDM) system, process optimization exercises and scope of Medidata Rave services. This Accreditation teaches the staff to perform end user training, user and site administration, study build, reporting, outputs and amendment manager.